Company performance
Add to research
Current Price
as of Mar 12, 2025$43.10
P/E Ratio
N/A
Market Cap
$5.32B
- GH
Description
Add to research
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.
Metrics
Add to research
Overview
- HQPalo Alto, CA
- SectorHealth Services
- IndustryMedical/Nursing Services
- TickerGH
- Price$43.1+1.10%
Trading Information
- Market cap$5.32B
- Float95.61%
- Average Daily Volume (1m)2,691,976
- Average Daily Volume (3m)2,371,243
- EPS-$3.56
Company
- Revenue$739.02M
- Rev growth (1yr)31.04%
- Net income-$436.37M
- Gross margin60.79%
- EBITDA margin-54.29%
- EBITDA-$401.21M
- EV$4.25B
- EV/Revenue5.75
- P/EN/A
- P/S7.16
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account